Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

193 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

NCT01807091

Conditions
Adult Acute Myeloid Leukemia, Adult Myelodysplastic Syndrome, Anemia, +11 more
Locations
  • Bozeman Deaconess Hospital Bozeman, Montana, United States
  • Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States
  • EvergreenHealth Medical Center Kirkland, Washington, United States
  • Skagit Valley Hospital Mount Vernon, Washington, United States
View Trial Details
Completed

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

NCT01241500

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Virginia G. Piper Cancer Center Scottsdale, Arizona, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 87 locations
View Trial Details
Completed

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

NCT01928537

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Stanford University Cancer Center Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Medicine Chicago, Illinois, United States
  • University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
View all 35 locations
View Trial Details
Completed

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

NCT01251575

Conditions
Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma, +67 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

NCT00008177

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +34 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions